View Author
asthma airway montelukast study patient treatment effect respir children nitric oxide placebo disease allergy sputum flammatory biomarker flammation rhiniti response ro flumilast inhaled level asthmatic oxide group nitric measurement symptom therapy allergen diamant immunol flumilast subject function leukotriene trial challenge lung function marker method exacerbation increase eosinophil control sampling allergen challenge inhaled corticosteroids technique addition adult phosphodiesterase breath signi pharmacology improvement barnes pj corticosteroids breath condensate diamant z methacholine therapeutic analysis baseline inflammation fev 1 combination cyslt asthmatic children inhibitor salmeterol asthma control score ef ficacy randomized budesonide receptor change reproducibility anti-in
6 Most Recent Publications
|
Biomarkers in asthma and allergic rhinitis
(Article)
Diamant, Z. Boot, J.D. Mantzouranis, E. Flohr, R. |
2010-12-01
|
|
Sputum induction with hypertonic saline reduces fractional exhaled nitric oxide in chronic smokers and non-smokers
(Article)
Zuiker, R.G.J.A. Boot, J.D. Calderon, C. Piantone, A. Petty, K. Kam, M. de Diamant, Z. |
2010-06-01
|
|
Add-on montelukast to inhaled corticosteroids protects against excessive airway narrowing
(Article)
Ulrik, C.S. Diamant, Z. |
2010-04-01
|
|
PDE4-inhibitors: A novel, targeted therapy for obstructive airways disease
(Article)
Diamant, Z. Spina, D. |
2010-01-01
|
|
Montelukast in the treatment of asthma and beyond
(Article)
Diamant, Z. Mantzouranis, E. Bjermer, L. |
2009-11-01
|
|
Nasal nitric oxide: Longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis
(Article)
Boot, J.D. Kam, M. de Mascelli, M.A. Miller, B. Wijk, R.G. van Groot, H. de Cohen, A.F. Diamant, Z. |
2007-04-01
|